Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Item TypeItem Type
-
SubjectSubject
-
YearFrom:-To:
-
More FiltersMore FiltersSourceLanguage
Done
Filters
Reset
18
result(s) for
"Moyer, Stephen E."
Sort by:
Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase
2006
The protein Cdc45 plays a critical but poorly understood role in the initiation and elongation stages of eukaryotic DNA replication. To study Cdc45's function in DNA replication, we purified Cdc45 protein from Drosophila embryo extracts by a combination of traditional and immunoaffinity chromatography steps and found that the protein exists in a stable, high-molecular-weight complex with the Mcm2-7 hexamer and the GINS tetramer. The purified Cdc45/Mcm2-7/GINS complex is associated with an active ATP-dependent DNA helicase function. RNA interference knock-down experiments targeting the GINS and Cdc45 components establish that the proteins are required for the S phase transition in Drosophila cells. The data suggest that this complex forms the core helicase machinery for eukaryotic DNA replication.
Journal Article
Isolation of the Cdc45/Mcm2–7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase
2006
The protein Cdc45 plays a critical but poorly understood role in the initiation and elongation stages of eukaryotic DNA replication. To study Cdc45's function in DNA replication, we purified Cdc45 protein from Drosophila embryo extracts by a combination of traditional and immunoaffinity chromatography steps and found that the protein exists in a stable, high-molecular-weight complex with the Mcm2–7 hexamer and the GINS tetramer. The purified Cdc45/Mcm2–7/GINS complex is associated with an active ATP-dependent DNA helicase function. RNA interference knock-down experiments targeting the GINS and Cdc45 components establish that the proteins are required for the S phase transition in Drosophila cells. The data suggest that this complex forms the core helicase machinery for eukaryotic DNA replication.
Journal Article
Isolation of the Cdc4S/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase
by
Botchan, Michael R
,
Moyer, Stephen E
,
Lewis, Peter W
in
Adenosine triphosphatase
,
Biochemistry
,
Deoxyribonucleic acid
2006
The protein Cdc45 plays a critical but poorly understood role in the initiation and elongation stages of eukaryotic DNA replication. To study Cdc45's function in DNA replication, we purified Cdc45 protein from Drosophila embryo extracts by a combination of traditional and immunoaffinity chromatography steps and found that the protein exists in a stable, high-molecular-weight complex with the McmZ-7 hexamer and the GINS tetramer. The purified Cdc45/McmZ-7/GINS complex is associated with an active ATP- dependent DNA helicase function. RNA interference knock-down experiments targeting the GINS and Cdc45 components establish that the proteins are required for the S phase transition in Drosophila cells. The data suggest that this complex forms the core helicase machinery for eukaryotic DNA replication. [PUBLICATION ABSTRACT]
Journal Article
Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure
2019
There are no FDA licensed vaccines or therapeutics for Venezuelan equine encephalitis virus (VEEV) which causes a debilitating acute febrile illness in humans that can progress to encephalitis. Previous studies demonstrated that murine and macaque monoclonal antibodies (mAbs) provide prophylactic and therapeutic efficacy against VEEV peripheral and aerosol challenge in mice. Additionally, humanized versions of two neutralizing mAbs specific for the E2 glycoprotein, 1A3B-7 and 1A4A-1, administered singly protected mice against aerosolized VEEV. However, no studies have demonstrated protection in nonhuman primate (NHP) models of VEEV infection. Here, we evaluated a chimeric antibody 1A3B-7 (c1A3B-7) containing mouse variable regions on a human IgG framework and a humanized antibody 1A4A-1 containing a serum half-life extension modification (Hu-1A4A-1-YTE) for their post-exposure efficacy in NHPs exposed to aerosolized VEEV. Approximately 24 hours after exposure, NHPs were administered a single bolus intravenous mAb. Control NHPs had typical biomarkers of VEEV infection including measurable viremia, fever, and lymphopenia. In contrast, c1A3B-7 treated NHPs had significant reductions in viremia and lymphopenia and on average approximately 50% reduction in fever. Although not statistically significant, Hu-1A4A-1-YTE administration did result in reductions in viremia and fever duration. Delay of treatment with c1A3B-7 to 48 hours post-exposure still provided NHPs protection from severe VEE disease through reductions in viremia and fever. These results demonstrate that post-exposure administration of c1A3B-7 protected macaques from development of severe VEE disease even when administered 48 hours following aerosol exposure and describe the first evaluations of VEEV-specific mAbs for post-exposure prophylactic use in NHPs. Viral mutations were identified in one NHP after c1A3B-7 treatment administered 24 hrs after virus exposure. This suggests that a cocktail-based therapy, or an alternative mAb against an epitope that cannot mutate without resulting in loss of viral fitness may be necessary for a highly effective therapeutic.
Journal Article
The Geological Record of Ocean Acidification
by
Royer, Dana L.
,
Schmidt, Daniela N.
,
Barker, Stephen
in
Acidification
,
Acidity
,
Adaptation, Biological
2012
Ocean acidification may have severe consequences for marine ecosystems; however, assessing its future impact is difficult because laboratory experiments and field observations are limited by their reduced ecologie complexity and sample period, respectively. In contrast, the geological record contains long-term evidence for a variety of global environmental perturbations, including ocean acidification plus their associated biotic responses. We review events exhibiting evidence for elevated atmospheric CO₂, global warming, and ocean acidification over the past ~300 million years of Earth's history, some with contemporaneous extinction or evolutionary turnover among marine calcifiers. Although similarities exist, no past event perfectly parallels future projections in terms of disrupting the balance of ocean carbonate chemistry—a consequence of the unprecedented rapidity of CO₂ release currently taking place.
Journal Article
The airborne chicago water isotope spectrometer: an integrated cavity output spectrometer for measurements of the HDO / H2O isotopic ratio in the Asian Summer Monsoon
2025
We describe a new version of the Chicago Water Isotope Spectrometer (ChiWIS), designed for airborne measurements of vapor-phase water isotopologues in the dry upper troposphere and lower stratosphere (UTLS) aboard research aircraft. This version of the instrument is a tunable diode laser (TDL), off-axis integrated cavity output spectrometer (OA-ICOS). The instrument was designed to measure the HDO / H2O ratio in the 2017 Asian Summer Monsoon flight aboard the M-55 Geophysica during the StratoClim campaign, and so far has also flown aboard the WB-57F in the 2021 and 2022 ACCLIP campaigns. The spectrometer scans absorption lines of both H2O and HDO near 2.647 µm wavelength in a single current sweep, and has an effective path length of 7.5 km under optimal conditions. The instrument utilizes a novel non-axially-symmetric optical component which increases the signal-to-noise ratio by a factor of 3. Ultra-polished, 4 in. (101.6 mm) diameter cavity mirrors suppress scattering losses, maximize mirror reflectivity, and yield optical fringing significantly below typical electrical noise levels. In laboratory conditions, the instrument has demonstrated a 5 s measurement precision of 3.6 ppbv and 82 pptv in H2O and HDO, respectively.
Journal Article
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
by
Wood, Brent L.
,
O’Brien, Maureen M.
,
Devidas, Meenakshi
in
Acute lymphoblastic leukemia
,
Antibodies, Bispecific - administration & dosage
,
Antibodies, Bispecific - adverse effects
2025
B-cell acute lymphoblastic leukemia (B-cell ALL) is the most common childhood cancer. Despite a high overall cure rate, relapsed B-cell ALL remains a leading cause of cancer-related death among children. The addition of the bispecific T-cell engager molecule blinatumomab (an anti-CD19 and anti-CD3 single-chain molecule) to therapy for newly diagnosed standard-risk (as defined by the National Cancer Institute) B-cell ALL in children may improve outcomes.
We conducted a phase 3 trial involving children with newly diagnosed standard-risk B-cell ALL who had an average or higher risk of relapse. Patients were randomly assigned to receive chemotherapy alone or chemotherapy plus two nonsequential 28-day cycles of blinatumomab. The primary end point was disease-free survival.
The data and safety monitoring committee reviewed the results from the first interim efficacy analysis, which included 1440 patients who had undergone randomization (722 to chemotherapy alone and 718 to blinatumomab and chemotherapy) and recommended early termination of randomization. At a median follow-up of 2.5 years, the estimated 3-year disease-free survival (±SE) was 96.0±1.2% with blinatumomab and chemotherapy and 87.9±2.1% with chemotherapy alone (difference in restricted mean survival time, 72 days; 95% confidence interval, 36 to 108; P<0.001 by stratified log-rank test). The estimated 3-year disease-free survival among patients with an average relapse risk was 97.5±1.3% with blinatumomab and chemotherapy and 90.2±2.3% with chemotherapy alone; among those with a higher relapse risk, the corresponding values were 94.1±2.5% and 84.8±3.8%. Cytokine release syndrome, seizures, and sepsis of grade 3 or higher were rare during blinatumomab cycles, but the overall incidence of nonfatal sepsis and catheter-related infections was significantly higher among patients with an average relapse risk who had been assigned to receive blinatumomab and chemotherapy than among those assigned to receive chemotherapy alone.
Adding blinatumomab to combination chemotherapy in patients with newly diagnosed childhood standard-risk B-cell ALL of average or higher risk of relapse significantly improved disease-free survival. (Funded by the National Institutes of Health and others; AALL1731 ClinicalTrials.gov number, NCT03914625.).
Journal Article
Accuracy and Precision of Tidal Wetland Soil Carbon Mapping in the Conterminous United States
by
Windham-Myers, Lisamarie
,
Buffington, Kevin
,
Smith, Erik
in
704/106/694/682
,
704/47/4113
,
Carbon
2018
Tidal wetlands produce long-term soil organic carbon (C) stocks. Thus for carbon accounting purposes, we need accurate and precise information on the magnitude and spatial distribution of those stocks. We assembled and analyzed an unprecedented soil core dataset, and tested three strategies for mapping carbon stocks: applying the average value from the synthesis to mapped tidal wetlands, applying models fit using empirical data and applied using soil, vegetation and salinity maps, and relying on independently generated soil carbon maps. Soil carbon stocks were far lower on average and varied less spatially and with depth than stocks calculated from available soils maps. Further, variation in carbon density was not well-predicted based on climate, salinity, vegetation, or soil classes. Instead, the assembled dataset showed that carbon density across the conterminous united states (CONUS) was normally distributed, with a predictable range of observations. We identified the simplest strategy, applying mean carbon density (27.0 kg C m
−3
), as the best performing strategy, and conservatively estimated that the top meter of CONUS tidal wetland soil contains 0.72 petagrams C. This strategy could provide standardization in CONUS tidal carbon accounting until such a time as modeling and mapping advancements can quantitatively improve accuracy and precision.
Journal Article
The airborne chicago water isotope spectrometer: an integrated cavity output spectrometer for measurements of the HDO / H.sub.2O isotopic ratio in the Asian Summer Monsoon
by
Sarkozy, Laszlo C
,
Singer, Clare E
,
Khaykin, Sergey
in
Equipment and supplies
,
Laboratories
,
Laboratory equipment
2025
We describe a new version of the Chicago Water Isotope Spectrometer (ChiWIS), designed for airborne measurements of vapor-phase water isotopologues in the dry upper troposphere and lower stratosphere (UTLS) aboard research aircraft. This version of the instrument is a tunable diode laser (TDL), off-axis integrated cavity output spectrometer (OA-ICOS). The instrument was designed to measure the HDO / H.sub.2 O ratio in the 2017 Asian Summer Monsoon flight aboard the M-55 Geophysica during the StratoClim campaign, and so far has also flown aboard the WB-57F in the 2021 and 2022 ACCLIP campaigns. The spectrometer scans absorption lines of both H.sub.2 O and HDO near 2.647 µm wavelength in a single current sweep, and has an effective path length of 7.5 km under optimal conditions. The instrument utilizes a novel non-axially-symmetric optical component which increases the signal-to-noise ratio by a factor of 3. Ultra-polished, 4 in. (101.6 mm) diameter cavity mirrors suppress scattering losses, maximize mirror reflectivity, and yield optical fringing significantly below typical electrical noise levels. In laboratory conditions, the instrument has demonstrated a 5 s measurement precision of 3.6 ppbv and 82 pptv in H.sub.2 O and HDO, respectively.
Journal Article